These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18069905)

  • 1. Momordica charantia (bitter melon). Monograph.
    Altern Med Rev; 2007 Dec; 12(4):360-3. PubMed ID: 18069905
    [No Abstract]   [Full Text] [Related]  

  • 2. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
    Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
    Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats.
    Senanayake GV; Maruyama M; Shibuya K; Sakono M; Fukuda N; Morishita T; Yukizaki C; Kawano M; Ohta H
    J Ethnopharmacol; 2004 Apr; 91(2-3):257-62. PubMed ID: 15120448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
    Inayat-ur-Rahman ; Malik SA; Bashir M; Khan R; Iqbal M
    Phytomedicine; 2009 May; 16(5):401-5. PubMed ID: 19362455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
    Krawinkel MB; Keding GB
    Nutr Rev; 2006 Jul; 64(7 Pt 1):331-7. PubMed ID: 16910221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does bitter melon contain an activator of AMP-activated kinase?
    McCarty MF
    Med Hypotheses; 2004; 63(2):340-3. PubMed ID: 15236800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of atrial fibrillation due to Momordica charantia (bitter melon).
    Erden I; Ordu S; Erden EC; Caglar SO
    Ann Saudi Med; 2010; 30(1):86-7. PubMed ID: 20103967
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
    Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB
    Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
    Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
    Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiulcer activity of methanolic extract of Momordica charantia L. in rats.
    Alam S; Asad M; Asdaq SM; Prasad VS
    J Ethnopharmacol; 2009 Jun; 123(3):464-9. PubMed ID: 19501279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
    Yaldız G; Sekeroglu N; Kulak M; Demirkol G
    Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraction, fractionation and characterization of bitter melon seed proteins.
    Horax R; Hettiarachchy N; Over K; Chen P; Gbur E
    J Agric Food Chem; 2010 Feb; 58(3):1892-7. PubMed ID: 20052973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.
    Snee LS; Nerurkar VR; Dooley DA; Efird JT; Shovic AC; Nerurkar PV
    Nutr J; 2011 Jul; 10():78. PubMed ID: 21794176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secret garden.
    Gelo F; Harris R
    Fam Med; 2009 Jun; 41(6):391-2. PubMed ID: 19492183
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
    Shetty AK; Kumar GS; Sambaiah K; Salimath PV
    Plant Foods Hum Nutr; 2005 Sep; 60(3):109-12. PubMed ID: 16187012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Trends On Drug Delivery Strategy of Momordica charantia against Diabetes and its Complications.
    Thent ZC; Das S; Zaidun NH
    Curr Drug Deliv; 2018; 15(4):453-460. PubMed ID: 28545355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.